Literature DB >> 489161

Large interindividual variations in metabolism of benzo(alpha)pyrene by peripheral lung tissue from lung cancer patients.

G M Cohen, R Mehta, M Meredith-Brown.   

Abstract

A very large variation (44-fold) was observed in the ability of short-term organ cultures of peripheral lung tissue from lung-cancer patients to metabolize the environmental carcinogen benzo(alpha)pyrene to organic solvent-soluble metabolites. The amounts of benzo(alpha)pyrene (2 microM) metabolized ranged from little (1%) to almost total (96.2%) metabolism within 24 h of culture. Previous work by Kellerman et al. (1973) has suggested a relationship between susceptibility to lung cancer and the indicibility of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. The metabolic fate of carcinogenic polycyclic aromatic hydrocarbons in the respiratory tract in vivo is undoubtedly more closely mimicked by short-term organ culture of human lung than by cultured lymphocytes. Thus the very wide interindividual variation observed in pulmonary metabolism of benzo(alpha)pyrene in this study and the large variations in covalent binding to human bronchial DNA observed by Harris et al. (1976) strongly suggest that there may be little basis for screening humans for variations in lymphocyte aryl hydrocarbon hydroxylase activity as a means of assessing their susceptibility to lung cancer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489161     DOI: 10.1002/ijc.2910240202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Phenanthrene metabolism in smokers: use of a two-step diagnostic plot approach to identify subjects with extensive metabolic activation.

Authors:  Jing Wang; Yan Zhong; Steven G Carmella; J Bradley Hochalter; Diane Rauch; Andrew Oliver; Joni Jensen; Dorothy K Hatsukami; Pramod Upadhyaya; Stephen S Hecht; Cheryl L Zimmerman
Journal:  J Pharmacol Exp Ther       Date:  2012-06-06       Impact factor: 4.030

Review 2.  Genetic predisposition to lung cancer.

Authors:  M R Law
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

3.  Immunohistochemical detection of anti-(+/-)-trans-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)p yrene-bound adduct in nuclei of cultured HeLa cells and mouse lung tissue.

Authors:  N Nemoto; Y Nakatsuru; K Nakagawa; A Tazawa; T Ishikawa
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 4.  Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.

Authors:  R M Philpot; B R Smith
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

5.  Chemical and biochemical dosimetry of exposure to genotoxic chemicals.

Authors:  G N Wogan; N J Gorelick
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

6.  Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer?

Authors:  K Pyykkö; R Tuimala; L Aalto; T Perkiö
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

7.  Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence.

Authors:  Jia-Ying Joey Lee; James Alastair Miller; Sreetama Basu; Ting-Zhen Vanessa Kee; Lit-Hsin Loo
Journal:  Arch Toxicol       Date:  2018-04-28       Impact factor: 5.153

Review 8.  Carcinogenicity of airborne fine particulate benzo(a)pyrene: an appraisal of the evidence and the need for control.

Authors:  F Perera
Journal:  Environ Health Perspect       Date:  1981-12       Impact factor: 9.031

Review 9.  Views on the aetiology of some cancers.

Authors:  D G Harnden
Journal:  J R Coll Physicians Lond       Date:  1980-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.